Albertsons Ordered to Pay $900M in Washington Opioid Case

Albertsons must pay Washington state $900 million for its pharmacies' role in fueling the opioid prescription crisis. Judge Janet Helson of King County Superior Court in Seattle issued the ruling Thursday. The court found the grocer failed to prevent misuse of highly addictive medication.

The verdict splits into two parts. Helson determined Albertsons owes an $800 million abatement plus $100 million in civil penalties. The judge ruled the company violated state and federal law by failing to maintain safeguards that could identify and resolve "red flags" indicating suspicious drug orders from its pharmacies.

How many prescriptions triggered red flags?

The number is large. Between 2006 and 2022, Albertsons filled more than 6.5 million opioid prescriptions in Washington state that triggered one or more "commonly accepted red flags," according to the ruling.

The court drew a direct line to problematic prescribers. Helson found Albertsons filled 5.5 million prescriptions from five "pill mill" doctors in the state. All five later had their licenses suspended or revoked.

The ruling placed responsibility squarely on the retailer. Helson noted it was Albertsons' duty to maintain systems that could identify and prevent suspicious prescriptions and to report those red flags to the authorities.

"Albertsons possessed, but routinely disregarded or ignored, information and tools that could have helped prevent diversion, choosing sales and profits over patient safety," the ruling stated.

What did Albertsons say?

Albertsons said in a statement it is "disappointed" by the ruling and may appeal. The company said it disagrees with the verdict and is evaluating its options.

At trial, the company defended its pharmacists. Albertsons argued its pharmacies "are a mirror of what the doctors are doing."

"We are proud of our pharmacists and their dedication to the patients and communities they serve, and we will continue to support our customers and communities across Washington through responsible pharmacy operations," Albertsons said in its statement.

What is the case background?

Washington state's attorney general sued Albertsons and several other pharmacy chains in 2022. The nine-week trial commenced this past summer in King County.

Thursday's ruling marks the latest legal and financial challenge for Albertsons. In April, the company announced a $774 million framework to settle most of the opioid-related claims brought against it nationally. That arrangement contributed to a nearly $500 million net loss in the fourth quarter of fiscal 2025.

Why the timing compounds Albertsons' problems?

The $900 million judgment lands on a company already under pressure on several fronts. Albertsons posted another quarter of declining comparable sales in its Q2 earnings last month. This past summer it restructured to streamline its operating divisions and center store merchandising.

The Kroger merger fight continues in parallel. Last week, Albertsons presented closing arguments in its case claiming Kroger is to blame for the failure of their proposed merger.

An appeal would extend the Washington litigation while the company manages the national settlement framework and its separate courtroom battle with Kroger. For pharmacy operators, the ruling reinforces that courts will hold retail chains liable for prescription monitoring failures, with penalties measured in the hundreds of millions.